Science Explorer Back to mapMap
Institution · Public.Resource.Org

Most cited papers from Public.Resource.Org

What are the most cited papers from Public.Resource.Org?

The most cited paper from Public.Resource.Org is "Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial" (Edith A. Perez, Ahmad Hussein Awada, Joyce O’Shaughnessy et al., 2015), with 91 citations. Next come "Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial" (52) and "Acid Dreams: The CIA, LSD and the Sixties Rebellion" (43).

Showing 18 of 18 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial Edith A. Perez, Ahmad Hussein Awada, Joyce O’Shaughnessy et al. · The Lancet Oncology 25 Oct 2015 91
2 Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial Javier Cortés, Hope S. Rugo, Ahmad Hussein Awada et al. · Breast Cancer Research and Treatment Open access 13 Jun 2017 52
3 Acid Dreams: The CIA, LSD and the Sixties Rebellion Robert Leverant · Journal of Psychoactive Drugs 1987 43
4 Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial Chris J. Twelves, Javier Cortés, Joyce O’Shaughnessy et al. · European Journal of Cancer Open access 27 Mar 2017 16
5 Grief as a Mystical Journey: Fowler’s Stages of Faith Development and Their Relation to Post-Traumatic Growth Terri Daniel · Journal of Pastoral Care & Counseling Advancing theory and professional practice through scholarly and reflective publications Dec 2017 14
6 Comment on the Treatment of Fibromyalgia Syndrome Using Low-Intensity Neurofeedback with the Flexyx Neurotherapy System: A Randomized Controlled Clinical Trial, or How to Go Crazy Over Nearly Nothing Len Ochs · Journal of Neurotherapy Open access 27 Dec 2006 8
7 Response to “Biodiversity’s option value: A comment on Maier (2018)” by Faith Donald S. Maier · AMBIO Open access 27 Jul 2018 6
8 Comment on “Neurofeedback Overtraining and the Vulnerable Patient” Len Ochs · Journal of Neurotherapy Open access 20 Jun 2008 6
9 Safety and tolerability of etirinotecan pegol in advanced breast cancer: analysis of the randomized, phase 3 BEACON trial Javier Cortés, Hope S. Rugo, Chris Twelves et al. · SpringerPlus Open access 8 Jul 2016 5
10 MDMA Reconsidered Robert Leverant · Journal of Psychoactive Drugs Oct 1986 4
11 Time-frequency strip filters B.A. Weisburn, R.G. Shenoy Conference paper 24 Dec 2002 3
12 Peter D'Amato Damon Collingsworth · Carnivorous Plant Newsletter Open access 2 May 2025 0
13 An Empirical Analysis of ‘Scandalous’ and ‘Obscene’ Trade Marks in India M. P. Ram Mohan, Aditya Gupta, Vijay V Venkitesh · SSRN Electronic Journal PreprintOpen access 2024 0
14 My 50 years of history in the field Len Ochs · Elsevier eBooks Book chapter 22 Nov 2019 0
15 Beyond blood brothers: queer Bruce Springsteen Rosalie Zdzienicka Fanshel · Popular Music 13 Sep 2013 0
16 P‐58: Reflectors with Phase Compensation fora Reflective LC Color Projection System Philip W. Baumeister · SID Symposium Digest of Technical Papers Conference paper May 1998 0
17 U.S. business—guilty as charged Judy C. Rice · National Productivity Review Dec 1994 0
18 Intoxication: Life in Pursuit of Artificial Paradise Robert Leverant · Journal of Psychoactive Drugs 1990 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.